Financials data is unavailable for this security.
View more
Year on year BlackRock Health Sciences Trust grew revenues 5.98% from 7.73m to 8.19m while net income improved from a loss of 26.47m to a gain of 20.02m.
| Gross margin | 100.00% |
|---|---|
| Net profit margin | 683.94% |
| Operating margin | 21.15% |
| Return on assets | 8.86% |
|---|---|
| Return on equity | 9.01% |
| Return on investment | 8.91% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at BlackRock Health Sciences Trust fell by 2.59k. However, the company earned 32.02m from its operations for a Cash Flow Margin of 390.78%. In addition the company used on investing activities and also paid 32.02m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 44.20 |
|---|---|
| Tangible book value per share | 44.20 |
More ▼
Balance sheet in USDView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0017 |
|---|---|
| Total debt/total capital | 0.0017 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 175.17%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 5.55% |
|---|---|
| Div growth rate (5 year) | 1.30% |
| Payout ratio (TTM) | 65.21% |
| EPS growth(5 years) | -8.86 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 17.76 |
More ▼
